Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 2,670 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of San Francisco Clear all

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 1 Year and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stage IA Breast Cancer, Stage IIA Breast Cancer
Interventions: Intraoperative Radiation Therapy, Laboratory Biomarker Analysis; Radiation · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 45 Years and older · Female only
Enrollment: 1,259 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2028
U.S. locations: 25
States / cities: Berkeley, California • Irvine, California • Los Angeles, California + 20 more

Conditions: Thrombotic Microangiopathies
Interventions: Defibrotide; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 30 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV/AIDS, Sexually Transmitted Diseases, Pre-exposure Prophylaxis, Risk Reduction
Interventions: LYNX, MyChoices; Behavioral
Lead sponsor: Public Health Foundation Enterprises, Inc.; Other
Eligibility: 15 Years to 29 Years · Male only
Enrollment: 381 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 8
States / cities: Tampa, Florida • Atlanta, Georgia • Chicago, Illinois + 5 more

Conditions: PD - Parkinson's Disease
Interventions: Medtronic Percept Deep Brain Stimulation (adaptive DBS), Medtronic Percept Deep Brain Stimulation (cDBS); Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 25 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hematopoietic Neoplasm, Malignant Solid Neoplasm, Lymphatic System Neoplasm
Interventions: Fitbit, Apple HealthKit-based devices; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Venous Thromboembolism, Pulmonary Embolus, Deep Vein Thrombosis
Interventions: Not listed
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Intermittent Claudication
Interventions: Metformin ER, placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 35 Years to 89 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Depression, Pain, Dyspnea, Quality of Life
Interventions: Symptom Management Service for Heart failure; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System
Interventions: Tranexamic Acid (TXA); Drug
Lead sponsor: Arbi Nazarian, MD; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Fresno, California

Conditions: Control Group, Counseling
Interventions: Brief and solutions-therapy intervention; Behavioral
Lead sponsor: University of San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Distress, Depression, Grief
Interventions: Psilocybin, Modified brief Supportive Expressive Group Therapy; Drug · Behavioral
Lead sponsor: Joshua Woolley; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: High Grade Glioma
Interventions: nanoliposomal irinotecan; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Morning Rounds, Teaching Rounds, Hospitalization, Inpatients, Quality Improvement
Interventions: Standardized attending morning rounds; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alopecia Areata
Interventions: Latanoprost (Xalatan), Bimatoprost (Lumigan), Topical application of latanoprost solution to eyelid; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 70 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Genetic Conditions, Genetic Disorders
Interventions: RNA sequencing; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 2 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Withdrawal Symptoms
Interventions: SSB withdrawal; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 13 Years to 18 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Oakland, California

Conditions: Atrial Fibrillation
Interventions: LARIAT Suture Delivery Device and Accessories; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 10
States / cities: Phoenix, Arizona • San Diego, California • San Francisco, California + 6 more

Conditions: Vascular Diseases
Interventions: Phenylephrine, Dexmedetomidine, Clevidipine, tetanic stimulus, Increased venous pressure, Calcium Chloride; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Myocardial Infarction, Ventricular Dysfunction, Sudden Death, Ventricular Tachycardia, Ventricular Fibrillation
Interventions: wearable defibrillator; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 57
States / cities: Anchorage, Alaska • Fresno, California • Salinas, California + 47 more

Conditions: Shoulder Dislocation
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Fresno, California

Conditions: Colorectal Carcinoma, Health Status Unknown, Healthy Subject
Interventions: Educational Intervention, Informational Intervention, Survey Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 75 Years
Enrollment: 982 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 4
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 1 more

Conditions: Obesity
Interventions: Naloxone, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study)

Evaluation of Vascular Pathology With 3D, Time-Resolved Phase Contrast Magnetic Resonance Imaging (MRI)

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery

Defibrotide TMA Prophylaxis Pilot Trial

Comparison of Men's Prevention Apps to Research Efficacy

Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Wearable Activity Tracking to Curb Hospitalizations

Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

Improving Care of Patients With Heart Failure

Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma

New at Parenting Study

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

RNA to the RESCUE: Evaluation to Assess the Clinical Utility of RNA Sequencing in Establishing a Genetic Diagnosis or Adjudicating a Previously Established Genetic Diagnosis.

The Potentially Addictive Properties of Soda: A Feasibility Study

Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - III

Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study

Vest Prevention of Early Sudden Death Trial and VEST Registry

Anterior Shoulder Dislocation

Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans

Biology and Experience of Eating in Women With Obesity